Gemma Tell

tell@clinic.cat 0000-0003-2728-6961

Publicaciones destacadas

Genetic Abnormalities in Large to Giant Congenital Nevi: Beyond NRAS mutations

Autores:
Martins da Silva V; Martinez-Barrios E; Tell-Martí G; Dabad M; Carrera C;

(...)

Esteve-Codina A; Vicente A; Puig S; Puig-Butillé JA; Malvehy J .

Referencia: Journal Of Investigative Dermatology 2019.
Melanocortin 1 receptor (MC1R) polymorphisms' influence on size and dermoscopic features of nevi.

Autores:
Gabriela Vallone, Maria; Tell-Marti, Gemma; Potrony, Miriam; Rebollo-Morell, Aida; Badenas, Celia;

Anton Puig-Butille, Joan; Gimenez-Xavier, Pol; Carrera, Cristina; Malvehy, Josep; Puig, Susana.

Referencia: Pigment Cell & Melanoma Research 2018.
The p. R151C Polymorphism in MC1R Gene Modifies the Age of Onset in Spanish Huntington’s Disease Patients

Autores:
Tell-Marti G.; Puig-Butille J.; Gimenez-Xavier P.; Segu-Roig A.; Potrony M.;

(...)

Millán J.; Trujillo-Tiebas M.; Ramos-Arroyo M.; Milà M.; Puig S..

Referencia: Molecular Neurobiology 2017.
IRF4 rs12203592 functional variant and melanoma survival.

Autores:
Potrony, Miriam; Rebollo-Morell, Aida; Gimenez-Xavier, Pol; Zimmer, Lisa; Puig-Butille, Joan Anton;

(...)

Badenas, Celia; Carrera, Cristina; Malvehy, Josep; Schadendorf, Dirk; Puig, Susana.

Referencia: International Journal Of Cancer 2017.
Genomic expression differences between cutaneous cells from red hair color individuals and black hair color individuals based on bioinformatic analysis

Autores:
Puig-Butille JA; Gimenez-Xavier P; Visconti A; Nsengimana J; Garcia-García F;

(...)

Bataille V; Del Río M; Dopazo J; Falchi M; Puig S .

Referencia: Oncotarget 2017.
AURKA Overexpression Is Driven by FOXM1 and MAPK/ERK Activation in Melanoma Cells Harboring BRAF or NRAS Mutations: Impact on Melanoma Prognosis and Therapy.

Autores:
Puig-Butille JA; Vinyals A; Ferreres JR; Aguilera P; Cabré E;

(...)

Piulats JM; Malvehy J; Pujana MA; Puig S; Fabra À .

Referencia: Journal Of Investigative Dermatology 2017.
A Common Variant in the MC1R Gene (p.V92M) is associated with Alzheimer's Disease Risk

Autores:
Tell-Marti G; Puig-Butille JA; Potrony M; Plana E; Badenas C;

(...)

Fortea J; Fernández-Santiago R; Clarimón J; Lladó A; Puig S .

Referencia: Journal Of Alzheimers Disease 2017.
Mutational status of naevus-associated melanomas

Autores:
Shitara, D.; Tell-Marti, G.; Badenas, C.; Enokihara, M. M. S. S.; Alos, L.;

(...)

Puig-Butille, J. A.; Carrera, C.; Malvehy, J.; Puig, S.; Bagatin, E.;.

Referencia: British Journal Of Dermatology 2015.
Capturing the biological impact of CDKN2A and MC1R genes as an early predisposing event in melanoma and non melanoma skin cancer

Autores:
Puig-Butille, Joan Anton; Escamez, Maria Jose; Garcia-Garcia, Francisco; Tell-Marti, Gemma; Fabra, Angels;

(...)

Aguilera, Paula; Pevida, Marta; Dopazo, Joaquin; del Rio, Marcela; Puig, Susana.

Referencia: Oncotarget 2014.

Proyectos destacados

Implementation of personalized medicine in cutaneous melanoma based on genomic susceptibility and tumor signatures: Identification of new targets for melanoma treatment.

Investigador/a principal: Marti R

Financiador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede); Fundació La Marató de TV3

Duración: 15/05/2014 - 31/12/2017
Evaluation of immunologic alterations underling development, progression and immunologic therapies response in melanoma. Implications of the microbiome in the tolerance induction and immuno-related adverse events in immunologic therapies.

Investigador/a principal: Puig S

Duración: 01/01/2016 - 31/12/2018
Distinct routes of metastatic dissemination in different melanoma subtypes. Implications in the validation of new tumor biomarkers and therapeutic targets.

Investigador/a principal: Piulats JM

Duración: 07/01/2015 - 30/06/2020
Papel del estrés oxidativo en el desarrollo del Melanoma Familiar y otras ER comunes con predisposición al desarrollo de neoplasias cutáneas

Duración: 01/01/2015 - 31/12/2015
Phenotype and molecular characterization of Large to Giant Congenital Melanocytic Nevi.

Investigador/a principal: Puig-Butille JA

Duración: 01/01/2015 - 31/12/2016

Gemma Tell

Publicaciones destacadas

Proyectos destacados

Implementation of personalized medicine in cutaneous melanoma based on genomic susceptibility and tumor signatures: Identification of new targets for melanoma treatment.

Evaluation of immunologic alterations underling development, progression and immunologic therapies response in melanoma. Implications of the microbiome in the tolerance induction and immuno-related adverse events in immunologic therapies.

Distinct routes of metastatic dissemination in different melanoma subtypes. Implications in the validation of new tumor biomarkers and therapeutic targets.

Papel del estrés oxidativo en el desarrollo del Melanoma Familiar y otras ER comunes con predisposición al desarrollo de neoplasias cutáneas

Phenotype and molecular characterization of Large to Giant Congenital Melanocytic Nevi.

Suscríbete a la Newsletter del Clínic